Bacteria Clinical Trials

1 recruiting

Bacteria Trials at a Glance

143 actively recruiting trials for bacteria are listed on ClinicalTrialsFinder across 6 cities in 52 countries. The largest study group is Not Applicable with 33 trials, with the heaviest enrollment activity in London, New York, and Toronto. Lead sponsors running bacteria studies include Assistance Publique - Hôpitaux de Paris, GramEye, and Children's Hospital of Fudan University.

Treatments under study

About Bacteria Clinical Trials

Looking for clinical trials for Bacteria? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bacteria trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bacteria clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 143 trials

Recruiting
Phase 2

A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)

Gram-negative Bacterial Infection
Pfizer48 enrolled29 locationsNCT06462235
Recruiting
Phase 2

Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children

Small Intestine Bacterial Overgrowth
University of Virginia60 enrolled1 locationNCT07451171
Recruiting
Phase 1

Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years

Pneumonia, Bacterial
GlaxoSmithKline120 enrolled2 locationsNCT07428759
Recruiting

Lung MRI in Paediatric Lung Disease: MRI in PBB

Protracted Bacterial Bronchitis (PBB)
Sheffield Children's NHS Foundation Trust30 enrolled1 locationNCT07545304
Recruiting

Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota

DysbiosisHPVMycosis+5 more
Centre National de la Recherche Scientifique, France300 enrolled1 locationNCT07199998
Recruiting
Phase 3

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Bacterial InfectionsHypogammaglobulinemia
Grifols Therapeutics LLC386 enrolled62 locationsNCT05645107
Recruiting
Early Phase 1

Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

Sexually Transmitted Diseases, Bacterial
University of California, San Francisco48 enrolled1 locationNCT06414408
Recruiting

Febrile Infants Swedish Study

Serious Bacterial InfectionSepsisBacteremia+4 more
Region Skane2,000 enrolled11 locationsNCT07134751
Recruiting
Not Applicable

Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.

Patient ParticipationBacterial InfectionsInfective Endocarditis+1 more
Region Halland50 enrolled1 locationNCT06704048
Recruiting
Not Applicable

Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections in Pediatrics

Severe Bacterial Infections
Nantes University Hospital1,401 enrolled6 locationsNCT07111793
Recruiting
Not Applicable

Exercise Program in Patients With Nontuberculous Mycobacterial Pulmonary Disease

Nontuberculous Mycobacterial Pulmonary Disease
Yonsei University50 enrolled1 locationNCT06488495
Recruiting

Changes Associated With H. Pylori and Gastric Carcinogenesis

Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Weill Medical College of Cornell University120 enrolled1 locationNCT02164409
Recruiting
Not Applicable

Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.

Infection, BacterialInfection Prevention
PENTA Foundation3,080 enrolled24 locationsNCT05993442
Recruiting
Phase 3

Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis

Endocarditis, Bacterial
University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)30 enrolled1 locationNCT06870409
Recruiting
Phase 1Phase 2

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS52 enrolled1 locationNCT04759001
Recruiting
Phase 3

Bacterial Reduction for a Manual Toothbrush With a 360-Degree Mouth Cleaner Design Versus a Standard Toothbrush

Bacterial Load Reduction
Colgate Palmolive60 enrolled1 locationNCT07471477
Recruiting
Phase 2

Subcutaneous Piperacillin/Tazobactam Compared With Intravenous Treatment

Bacteria InfectionPiperacillin, Tazobactam Drug Combination
Azienda Sanitaria Universitaria Friuli Centrale240 enrolled1 locationNCT07481539
Recruiting
Phase 3

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis
Baxis Pharmaceuticals, Inc.400 enrolled38 locationsNCT06911424
Recruiting
Phase 4

Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB

Ceftazidime-avibactamAztreonamGram-negative Bacterial Infection+2 more
Jing Zhou144 enrolled1 locationNCT07478484
Recruiting

Preparing for Maternal GBS Vaccine Trials in Africa

Invasive Bacterial Diseases (IBD)Group B StreptococcusMaternal Immunization
Barcelona Institute for Global Health18,100 enrolled9 locationsNCT06833957